The global mutational analysis market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.4 billion in 2026 to USD 7.5 billion by 2033, at a CAGR of 17.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 42.8% in 2025. The market growth is driven by increasing adoption of next-generation sequencing and molecular profiling technologies, growing demand for precision medicine, and expanding applications of mutational analysis in cancer genomics, inherited disease diagnosis, and drug development.
Global Mutational Analysis Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global mutational analysis market on the basis of mutation type, technology, product & service, end use, and region.Mutation Type Outlook (Revenue, USD Million, 2021-2033)
- SNVs/Point Mutations
- Indels
- Copy Number Variants
- Structural Variants
- Repeat Expansions
- Other Mutations
Technology Outlook (Revenue, USD Million, 2021-2033)
- Sequencing-based
- PCR-based
- Microarray-based
- CRISPR-based
- Other Molecular Methods
Product & Service Outlook (Revenue, USD Million, 2021-2033)
- Instruments & Equipment
- Consumables & Reagents
- Software & Bioinformatics
- Testing & Analytical Services
End Use Outlook (Revenue, USD Million, 2021-2033)
- Clinical & Diagnostics
- Precision Medicine
- Research & Drug Development
- Academic/CRO Research
- Others
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Mutation Type Segment
1.1.1.2. Technology Segment
1.1.1.3. Product & Service Segment
1.1.1.4. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. The internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. List of Secondary Sources
1.9.3. List of Abbreviations
1.1.1. Segment Definitions
1.1.1.1. Mutation Type Segment
1.1.1.2. Technology Segment
1.1.1.3. Product & Service Segment
1.1.1.4. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. The internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. List of Secondary Sources
1.9.3. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand for Comprehensive Detection of Genomic Mutations
3.2.1.2. Rising Adoption of Mutation Analysis in Precision Oncology and Targeted Therapy
3.2.1.3. Advancements in Sequencing Technologies for Mutation Detection
3.2.2. Market Restraint Analysis
3.2.2.1. High Costs and Uneven Reimbursement for Mutation and Genomic Testing
3.2.2.2. Technical Limitations in Detecting Complex and Low-Frequency Mutations
3.2.3. Market Opportunities Analysis
3.2.4. Market Challenges Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Social landscape
3.3.2.4. Economic landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand for Comprehensive Detection of Genomic Mutations
3.2.1.2. Rising Adoption of Mutation Analysis in Precision Oncology and Targeted Therapy
3.2.1.3. Advancements in Sequencing Technologies for Mutation Detection
3.2.2. Market Restraint Analysis
3.2.2.1. High Costs and Uneven Reimbursement for Mutation and Genomic Testing
3.2.2.2. Technical Limitations in Detecting Complex and Low-Frequency Mutations
3.2.3. Market Opportunities Analysis
3.2.4. Market Challenges Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Social landscape
3.3.2.4. Economic landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
Chapter 4. Mutation Type Business Analysis
4.1. Segment Dashboard
4.2. Mutational Analysis Market: Mutation Type Movement Analysis
4.3. SNVs/Point Mutations
4.3.1. SNVs/Point Mutations Market, 2021-2033 (USD Million)
4.4. Indels
4.4.1. Indels Market, 2021-2033 (USD Million)
4.5. Copy Number Variants
4.5.1. Copy Number Variants Market, 2021-2033 (USD Million)
4.6. Structural Variants
4.6.1. Structural Variants Market, 2021-2033 (USD Million)
4.7. Repeat Expansions
4.7.1. Repeat Expansions Market, 2021-2033 (USD Million)
4.8. Other Mutations
4.8.1. Other Mutations Market, 2021-2033 (USD Million)
4.2. Mutational Analysis Market: Mutation Type Movement Analysis
4.3. SNVs/Point Mutations
4.3.1. SNVs/Point Mutations Market, 2021-2033 (USD Million)
4.4. Indels
4.4.1. Indels Market, 2021-2033 (USD Million)
4.5. Copy Number Variants
4.5.1. Copy Number Variants Market, 2021-2033 (USD Million)
4.6. Structural Variants
4.6.1. Structural Variants Market, 2021-2033 (USD Million)
4.7. Repeat Expansions
4.7.1. Repeat Expansions Market, 2021-2033 (USD Million)
4.8. Other Mutations
4.8.1. Other Mutations Market, 2021-2033 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Segment Dashboard
5.2. Mutational Analysis Market: Technology Movement Analysis
5.3. Sequencing-based
5.3.1. Sequencing-based Market, 2021-2033 (USD Million)
5.4. PCR-based
5.4.1. PCR-based Market, 2021-2033 (USD Million)
5.5. Microarray-based
5.5.1. Microarray-based Market, 2021-2033 (USD Million)
5.6. CRISPR-based
5.6.1. CRISPR-based Market, 2021-2033 (USD Million)
5.7. Other Molecular Methods
5.7.1. Other Molecular Methods Market, 2021-2033 (USD Million)
5.2. Mutational Analysis Market: Technology Movement Analysis
5.3. Sequencing-based
5.3.1. Sequencing-based Market, 2021-2033 (USD Million)
5.4. PCR-based
5.4.1. PCR-based Market, 2021-2033 (USD Million)
5.5. Microarray-based
5.5.1. Microarray-based Market, 2021-2033 (USD Million)
5.6. CRISPR-based
5.6.1. CRISPR-based Market, 2021-2033 (USD Million)
5.7. Other Molecular Methods
5.7.1. Other Molecular Methods Market, 2021-2033 (USD Million)
Chapter 6. Product & Service Business Analysis
6.1. Segment Dashboard
6.2. Mutational Analysis Market: Product & Service Movement Analysis
6.3. Instruments & Equipment
6.3.1. Instruments & Equipment Market, 2021-2033 (USD Million)
6.4. Consumables & Reagents
6.4.1. Consumables & Reagents Market, 2021-2033 (USD Million)
6.5. Software & Bioinformatics
6.5.1. Software & Bioinformatics Market, 2021-2033 (USD Million)
6.6. Testing & Analytical Services
6.6.1. Testing & Analytical Services Market, 2021-2033 (USD Million) \
6.2. Mutational Analysis Market: Product & Service Movement Analysis
6.3. Instruments & Equipment
6.3.1. Instruments & Equipment Market, 2021-2033 (USD Million)
6.4. Consumables & Reagents
6.4.1. Consumables & Reagents Market, 2021-2033 (USD Million)
6.5. Software & Bioinformatics
6.5.1. Software & Bioinformatics Market, 2021-2033 (USD Million)
6.6. Testing & Analytical Services
6.6.1. Testing & Analytical Services Market, 2021-2033 (USD Million) \
Chapter 7. End Use Business Analysis
7.1. Segment Dashboard
7.2. Mutational Analysis Market: End Use Movement Analysis
7.3. Clinical & Diagnostics
7.3.1. Clinical & Diagnostics Market, 2021-2033 (USD Million)
7.4. Precision Medicine
7.4.1. Precision Medicine Market, 2021-2033 (USD Million)
7.5. Research & Drug Development
7.5.1. Research & Drug Development Market, 2021-2033 (USD Million)
7.6. Academic/CRO Research
7.6.1. Academic/CRO Research Market, 2021-2033 (USD Million)
7.7. Others
7.7.1. Others Market, 2021-2033 (USD Million)
7.2. Mutational Analysis Market: End Use Movement Analysis
7.3. Clinical & Diagnostics
7.3.1. Clinical & Diagnostics Market, 2021-2033 (USD Million)
7.4. Precision Medicine
7.4.1. Precision Medicine Market, 2021-2033 (USD Million)
7.5. Research & Drug Development
7.5.1. Research & Drug Development Market, 2021-2033 (USD Million)
7.6. Academic/CRO Research
7.6.1. Academic/CRO Research Market, 2021-2033 (USD Million)
7.7. Others
7.7.1. Others Market, 2021-2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Mutational Analysis Market Share by Region, 2025 & 2033
8.2. North America
8.2.1. North America Mutational Analysis Market, 2021-2033 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. U.S. Mutational Analysis Market, 2021-2033 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Canada Mutational Analysis Market, 2021-2033 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Mexico Mutational Analysis Market, 2021-2033 (USD Million)
8.3. Europe
8.3.1. Europe Mutational Analysis Market, 2021-2033 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. UK Mutational Analysis Market, 2021-2033 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Germany Mutational Analysis Market, 2021-2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France Mutational Analysis Market, 2021-2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy Mutational Analysis Market, 2021-2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain Mutational Analysis Market, 2021-2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Denmark Mutational Analysis Market, 2021-2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Sweden Mutational Analysis Market, 2021-2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Norway Mutational Analysis Market, 2021-2033 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Mutational Analysis Market, 2021-2033 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Japan Mutational Analysis Market, 2021-2033 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. China Mutational Analysis Market, 2021-2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. India Mutational Analysis Market, 2021-2033 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Australia Mutational Analysis Market, 2021-2033 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Thailand Mutational Analysis Market, 2021-2033 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. South Korea Mutational Analysis Market, 2021-2033 (USD Million)
8.5. Latin America
8.5.1. Latin America Mutational Analysis Market, 2021-2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Brazil Mutational Analysis Market, 2021-2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Argentina Mutational Analysis Market, 2021-2033 (USD Million)
8.6. MEA
8.6.1. MEA Mutational Analysis Market, 2021-2033 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. South Africa Mutational Analysis Market, 2021-2033 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Saudi Arabia Mutational Analysis Market, 2021-2033 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. UAE Mutational Analysis Market, 2021-2033 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Kuwait Mutational Analysis Market, 2021-2033 (USD Million)
8.2. North America
8.2.1. North America Mutational Analysis Market, 2021-2033 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. U.S. Mutational Analysis Market, 2021-2033 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Canada Mutational Analysis Market, 2021-2033 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Mexico Mutational Analysis Market, 2021-2033 (USD Million)
8.3. Europe
8.3.1. Europe Mutational Analysis Market, 2021-2033 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. UK Mutational Analysis Market, 2021-2033 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Germany Mutational Analysis Market, 2021-2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France Mutational Analysis Market, 2021-2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy Mutational Analysis Market, 2021-2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain Mutational Analysis Market, 2021-2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Denmark Mutational Analysis Market, 2021-2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Sweden Mutational Analysis Market, 2021-2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Norway Mutational Analysis Market, 2021-2033 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Mutational Analysis Market, 2021-2033 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Japan Mutational Analysis Market, 2021-2033 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. China Mutational Analysis Market, 2021-2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. India Mutational Analysis Market, 2021-2033 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Australia Mutational Analysis Market, 2021-2033 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Thailand Mutational Analysis Market, 2021-2033 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. South Korea Mutational Analysis Market, 2021-2033 (USD Million)
8.5. Latin America
8.5.1. Latin America Mutational Analysis Market, 2021-2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Brazil Mutational Analysis Market, 2021-2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Argentina Mutational Analysis Market, 2021-2033 (USD Million)
8.6. MEA
8.6.1. MEA Mutational Analysis Market, 2021-2033 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. South Africa Mutational Analysis Market, 2021-2033 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Saudi Arabia Mutational Analysis Market, 2021-2033 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. UAE Mutational Analysis Market, 2021-2033 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Kuwait Mutational Analysis Market, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Company Market Share/ Position Analysis, 2025
9.3. Strategy Mapping
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Type Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Illumina, Inc
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Type Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. F. Hoffmann-La Roche Ltd
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Type Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. QIAGEN
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Type Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Agilent Technologies, Inc.
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Type Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Bio-Rad Laboratories, Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Type Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Oxford Nanopore Technologies plc.
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Type Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. PacBio
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Type Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Takara Bio Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Type Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Revvity
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Type Benchmarking
9.4.10.4. Strategic Initiatives
9.4.10.5. Overview
9.4.10.6. Financial Performance
9.4.10.7. Product Type Benchmarking
9.4.10.8. Strategic Initiatives
9.2. Company Market Share/ Position Analysis, 2025
9.3. Strategy Mapping
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Type Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Illumina, Inc
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Type Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. F. Hoffmann-La Roche Ltd
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Type Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. QIAGEN
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Type Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Agilent Technologies, Inc.
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Type Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Bio-Rad Laboratories, Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Type Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Oxford Nanopore Technologies plc.
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Type Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. PacBio
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Type Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Takara Bio Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Type Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Revvity
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Type Benchmarking
9.4.10.4. Strategic Initiatives
9.4.10.5. Overview
9.4.10.6. Financial Performance
9.4.10.7. Product Type Benchmarking
9.4.10.8. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global mutational analysis market, mutation type, 2021-2033 (USD million)
Table 4 Global mutational analysis market, technology, 2021-2033 (USD million)
Table 5 Global mutational analysis market, product & service, 2021-2033 (USD million)
Table 6 Global mutational analysis market, end use, 2021-2033 (USD million)
Table 7 Global mutational analysis market, region, 2021-2033 (USD million)
Table 8 North America mutational analysis market, country, 2021-2033 (USD million)
Table 9 North America mutational analysis market, mutation type, 2021-2033 (USD million)
Table 10 North America mutational analysis market, technology, 2021-2033 (USD million)
Table 11 North America mutational analysis market, product & service, 2021-2033 (USD million)
Table 12 North America mutational analysis market, end use, 2021-2033 (USD million)
Table 13 U.S. mutational analysis market, mutation type, 2021-2033 (USD million)
Table 14 U.S. mutational analysis market, technology, 2021-2033 (USD million)
Table 15 U.S. mutational analysis market, product & service, 2021-2033 (USD million)
Table 16 U.S. mutational analysis market, end use, 2021-2033 (USD million)
Table 17 Canada mutational analysis market, mutation type, 2021-2033 (USD million)
Table 18 Canada mutational analysis market, technology, 2021-2033 (USD million)
Table 19 Canada mutational analysis market, product & service, 2021-2033 (USD million)
Table 20 Canada mutational analysis market, end use, 2021-2033 (USD million)
Table 21 Mexico mutational analysis market, mutation type, 2021-2033 (USD million)
Table 22 Mexico mutational analysis market, technology, 2021-2033 (USD million)
Table 23 Mexico mutational analysis market, product & service, 2021-2033 (USD million)
Table 24 Mexico mutational analysis market, end use, 2021-2033 (USD million)
Table 25 Europe mutational analysis market, country, 2021-2033 (USD million)
Table 26 Europe mutational analysis market, mutation type, 2021-2033 (USD million)
Table 27 Europe mutational analysis market, technology, 2021-2033 (USD million)
Table 28 Europe mutational analysis market, product & service, 2021-2033 (USD million)
Table 29 Europe mutational analysis market, end use, 2021-2033 (USD million)
Table 30 UK mutational analysis market, mutation type, 2021-2033 (USD million)
Table 31 UK mutational analysis market, technology, 2021-2033 (USD million)
Table 32 UK mutational analysis market, product & service, 2021-2033 (USD million)
Table 33 UK mutational analysis market, end use, 2021-2033 (USD million)
Table 34 Germany mutational analysis market, mutation type, 2021-2033 (USD million)
Table 35 Germany mutational analysis market, technology, 2021-2033 (USD million)
Table 36 Germany mutational analysis market, product & service, 2021-2033 (USD million)
Table 37 Germany mutational analysis market, end use, 2021-2033 (USD million)
Table 38 France mutational analysis market, mutation type, 2021-2033 (USD million)
Table 39 France mutational analysis market, technology, 2021-2033 (USD million)
Table 40 France mutational analysis market, product & service, 2021-2033 (USD million)
Table 41 France mutational analysis market, end use, 2021-2033 (USD million)
Table 42 Italy mutational analysis market, mutation type, 2021-2033 (USD million)
Table 43 Italy mutational analysis market, technology, 2021-2033 (USD million)
Table 44 Italy mutational analysis market, product & service, 2021-2033 (USD million)
Table 45 Italy mutational analysis market, end use, 2021-2033 (USD million)
Table 46 Spain mutational analysis market, mutation type, 2021-2033 (USD million)
Table 47 Spain mutational analysis market, technology, 2021-2033 (USD million)
Table 48 Spain mutational analysis market, product & service, 2021-2033 (USD million)
Table 49 Spain mutational analysis market, end use, 2021-2033 (USD million)
Table 50 Denmark mutational analysis market, mutation type, 2021-2033 (USD million)
Table 51 Denmark mutational analysis market, technology, 2021-2033 (USD million)
Table 52 Denmark mutational analysis market, product & service, 2021-2033 (USD million)
Table 53 Denmark mutational analysis market, end use, 2021-2033 (USD million)
Table 54 Sweden mutational analysis market, mutation type, 2021-2033 (USD million)
Table 55 Sweden mutational analysis market, technology, 2021-2033 (USD million)
Table 56 Sweden mutational analysis market, product & service, 2021-2033 (USD million)
Table 57 Sweden mutational analysis market, end use, 2021-2033 (USD million)
Table 58 Norway mutational analysis market, mutation type, 2021-2033 (USD million)
Table 59 Norway mutational analysis market, technology, 2021-2033 (USD million)
Table 60 Norway mutational analysis market, product & service, 2021-2033 (USD million)
Table 61 Norway mutational analysis market, end use, 2021-2033 (USD million)
Table 62 Asia Pacific mutational analysis market, country, 2021-2033 (USD million)
Table 63 Asia Pacific mutational analysis market, mutation type, 2021-2033 (USD million)
Table 64 Asia Pacific mutational analysis market, technology, 2021-2033 (USD million)
Table 65 Asia Pacific mutational analysis market, product & service, 2021-2033 (USD million)
Table 66 Asia Pacific mutational analysis market, end use, 2021-2033 (USD million)
Table 67 Japan mutational analysis market, mutation type, 2021-2033 (USD million)
Table 68 Japan mutational analysis market, technology, 2021-2033 (USD million)
Table 69 Japan mutational analysis market, product & service, 2021-2033 (USD million)
Table 70 Japan mutational analysis market, end use, 2021-2033 (USD million)
Table 71 China mutational analysis market, mutation type, 2021-2033 (USD million)
Table 72 China mutational analysis market, technology, 2021-2033 (USD million)
Table 73 China mutational analysis market, product & service, 2021-2033 (USD million)
Table 74 China mutational analysis market, end use, 2021-2033 (USD million)
Table 75 India mutational analysis market, mutation type, 2021-2033 (USD million)
Table 76 India mutational analysis market, technology, 2021-2033 (USD million)
Table 77 India mutational analysis market, product & service, 2021-2033 (USD million)
Table 78 India mutational analysis market, end use, 2021-2033 (USD million)
Table 79 Australia mutational analysis market, mutation type, 2021-2033 (USD million)
Table 80 Australia mutational analysis market, technology, 2021-2033 (USD million)
Table 81 Australia mutational analysis market, product & service, 2021-2033 (USD million)
Table 82 Australia mutational analysis market, end use, 2021-2033 (USD million)
Table 83 Thailand mutational analysis market, mutation type, 2021-2033 (USD million)
Table 84 Thailand mutational analysis market, technology, 2021-2033 (USD million)
Table 85 Thailand mutational analysis market, product & service, 2021-2033 (USD million)
Table 86 Thailand mutational analysis market, end use, 2021-2033 (USD million)
Table 87 South Korea mutational analysis market, mutation type, 2021-2033 (USD million)
Table 88 South Korea mutational analysis market, technology, 2021-2033 (USD million)
Table 89 South Korea mutational analysis market, product & service, 2021-2033 (USD million)
Table 90 South Korea mutational analysis market, end use, 2021-2033 (USD million)
Table 91 Latin America mutational analysis market, country, 2021-2033 (USD million)
Table 92 Latin America mutational analysis market, mutation type, 2021-2033 (USD million)
Table 93 Latin America mutational analysis market, technology, 2021-2033 (USD million)
Table 94 Latin America mutational analysis market, product & service, 2021-2033 (USD million)
Table 95 Latin America mutational analysis market, end use, 2021-2033 (USD million)
Table 96 Brazil mutational analysis market, mutation type, 2021-2033 (USD million)
Table 97 Brazil mutational analysis market, technology, 2021-2033 (USD million)
Table 98 Brazil mutational analysis market, product & service, 2021-2033 (USD million)
Table 99 Brazil mutational analysis market, end use, 2021-2033 (USD million)
Table 100 Argentina mutational analysis market, mutation type, 2021-2033 (USD million)
Table 101 Argentina mutational analysis market, technology, 2021-2033 (USD million)
Table 102 Argentina mutational analysis market, product & service, 2021-2033 (USD million)
Table 103 Argentina mutational analysis market, end use, 2021-2033 (USD million)
Table 104 Middle East & Africa mutational analysis market, country, 2021-2033 (USD million)
Table 105 Middle East & Africa mutational analysis market, mutation type, 2021-2033 (USD million)
Table 106 Middle East & Africa mutational analysis market, technology, 2021-2033 (USD million)
Table 107 Middle East & Africa mutational analysis market, product & service, 2021-2033 (USD million)
Table 108 Middle East & Africa mutational analysis market, end use, 2021-2033 (USD million)
Table 109 South Africa mutational analysis market, mutation type, 2021-2033 (USD million)
Table 110 South Africa mutational analysis market, technology, 2021-2033 (USD million)
Table 111 South Africa mutational analysis market, product & service, 2021-2033 (USD million)
Table 112 South Africa mutational analysis market, end use, 2021-2033 (USD million)
Table 113 Saudi Arabia mutational analysis market, mutation type, 2021-2033 (USD million)
Table 114 Saudi Arabia mutational analysis market, technology, 2021-2033 (USD million)
Table 115 Saudi Arabia mutational analysis market, product & service, 2021-2033 (USD million)
Table 116 Saudi Arabia mutational analysis market, end use, 2021-2033 (USD million)
Table 117 UAE mutational analysis market, mutation type, 2021-2033 (USD million)
Table 118 UAE mutational analysis market, technology, 2021-2033 (USD million)
Table 119 UAE mutational analysis market, product & service, 2021-2033 (USD million)
Table 120 UAE mutational analysis market, end use, 2021-2033 (USD million)
Table 121 Kuwait mutational analysis market, mutation type, 2021-2033 (USD million)
Table 122 Kuwait mutational analysis market, technology, 2021-2033 (USD million)
Table 123 Kuwait mutational analysis market, product & service, 2021-2033 (USD million)
Table 124 Kuwait mutational analysis market, end use, 2021-2033 (USD million)
Table 2 List of abbreviations
Table 3 Global mutational analysis market, mutation type, 2021-2033 (USD million)
Table 4 Global mutational analysis market, technology, 2021-2033 (USD million)
Table 5 Global mutational analysis market, product & service, 2021-2033 (USD million)
Table 6 Global mutational analysis market, end use, 2021-2033 (USD million)
Table 7 Global mutational analysis market, region, 2021-2033 (USD million)
Table 8 North America mutational analysis market, country, 2021-2033 (USD million)
Table 9 North America mutational analysis market, mutation type, 2021-2033 (USD million)
Table 10 North America mutational analysis market, technology, 2021-2033 (USD million)
Table 11 North America mutational analysis market, product & service, 2021-2033 (USD million)
Table 12 North America mutational analysis market, end use, 2021-2033 (USD million)
Table 13 U.S. mutational analysis market, mutation type, 2021-2033 (USD million)
Table 14 U.S. mutational analysis market, technology, 2021-2033 (USD million)
Table 15 U.S. mutational analysis market, product & service, 2021-2033 (USD million)
Table 16 U.S. mutational analysis market, end use, 2021-2033 (USD million)
Table 17 Canada mutational analysis market, mutation type, 2021-2033 (USD million)
Table 18 Canada mutational analysis market, technology, 2021-2033 (USD million)
Table 19 Canada mutational analysis market, product & service, 2021-2033 (USD million)
Table 20 Canada mutational analysis market, end use, 2021-2033 (USD million)
Table 21 Mexico mutational analysis market, mutation type, 2021-2033 (USD million)
Table 22 Mexico mutational analysis market, technology, 2021-2033 (USD million)
Table 23 Mexico mutational analysis market, product & service, 2021-2033 (USD million)
Table 24 Mexico mutational analysis market, end use, 2021-2033 (USD million)
Table 25 Europe mutational analysis market, country, 2021-2033 (USD million)
Table 26 Europe mutational analysis market, mutation type, 2021-2033 (USD million)
Table 27 Europe mutational analysis market, technology, 2021-2033 (USD million)
Table 28 Europe mutational analysis market, product & service, 2021-2033 (USD million)
Table 29 Europe mutational analysis market, end use, 2021-2033 (USD million)
Table 30 UK mutational analysis market, mutation type, 2021-2033 (USD million)
Table 31 UK mutational analysis market, technology, 2021-2033 (USD million)
Table 32 UK mutational analysis market, product & service, 2021-2033 (USD million)
Table 33 UK mutational analysis market, end use, 2021-2033 (USD million)
Table 34 Germany mutational analysis market, mutation type, 2021-2033 (USD million)
Table 35 Germany mutational analysis market, technology, 2021-2033 (USD million)
Table 36 Germany mutational analysis market, product & service, 2021-2033 (USD million)
Table 37 Germany mutational analysis market, end use, 2021-2033 (USD million)
Table 38 France mutational analysis market, mutation type, 2021-2033 (USD million)
Table 39 France mutational analysis market, technology, 2021-2033 (USD million)
Table 40 France mutational analysis market, product & service, 2021-2033 (USD million)
Table 41 France mutational analysis market, end use, 2021-2033 (USD million)
Table 42 Italy mutational analysis market, mutation type, 2021-2033 (USD million)
Table 43 Italy mutational analysis market, technology, 2021-2033 (USD million)
Table 44 Italy mutational analysis market, product & service, 2021-2033 (USD million)
Table 45 Italy mutational analysis market, end use, 2021-2033 (USD million)
Table 46 Spain mutational analysis market, mutation type, 2021-2033 (USD million)
Table 47 Spain mutational analysis market, technology, 2021-2033 (USD million)
Table 48 Spain mutational analysis market, product & service, 2021-2033 (USD million)
Table 49 Spain mutational analysis market, end use, 2021-2033 (USD million)
Table 50 Denmark mutational analysis market, mutation type, 2021-2033 (USD million)
Table 51 Denmark mutational analysis market, technology, 2021-2033 (USD million)
Table 52 Denmark mutational analysis market, product & service, 2021-2033 (USD million)
Table 53 Denmark mutational analysis market, end use, 2021-2033 (USD million)
Table 54 Sweden mutational analysis market, mutation type, 2021-2033 (USD million)
Table 55 Sweden mutational analysis market, technology, 2021-2033 (USD million)
Table 56 Sweden mutational analysis market, product & service, 2021-2033 (USD million)
Table 57 Sweden mutational analysis market, end use, 2021-2033 (USD million)
Table 58 Norway mutational analysis market, mutation type, 2021-2033 (USD million)
Table 59 Norway mutational analysis market, technology, 2021-2033 (USD million)
Table 60 Norway mutational analysis market, product & service, 2021-2033 (USD million)
Table 61 Norway mutational analysis market, end use, 2021-2033 (USD million)
Table 62 Asia Pacific mutational analysis market, country, 2021-2033 (USD million)
Table 63 Asia Pacific mutational analysis market, mutation type, 2021-2033 (USD million)
Table 64 Asia Pacific mutational analysis market, technology, 2021-2033 (USD million)
Table 65 Asia Pacific mutational analysis market, product & service, 2021-2033 (USD million)
Table 66 Asia Pacific mutational analysis market, end use, 2021-2033 (USD million)
Table 67 Japan mutational analysis market, mutation type, 2021-2033 (USD million)
Table 68 Japan mutational analysis market, technology, 2021-2033 (USD million)
Table 69 Japan mutational analysis market, product & service, 2021-2033 (USD million)
Table 70 Japan mutational analysis market, end use, 2021-2033 (USD million)
Table 71 China mutational analysis market, mutation type, 2021-2033 (USD million)
Table 72 China mutational analysis market, technology, 2021-2033 (USD million)
Table 73 China mutational analysis market, product & service, 2021-2033 (USD million)
Table 74 China mutational analysis market, end use, 2021-2033 (USD million)
Table 75 India mutational analysis market, mutation type, 2021-2033 (USD million)
Table 76 India mutational analysis market, technology, 2021-2033 (USD million)
Table 77 India mutational analysis market, product & service, 2021-2033 (USD million)
Table 78 India mutational analysis market, end use, 2021-2033 (USD million)
Table 79 Australia mutational analysis market, mutation type, 2021-2033 (USD million)
Table 80 Australia mutational analysis market, technology, 2021-2033 (USD million)
Table 81 Australia mutational analysis market, product & service, 2021-2033 (USD million)
Table 82 Australia mutational analysis market, end use, 2021-2033 (USD million)
Table 83 Thailand mutational analysis market, mutation type, 2021-2033 (USD million)
Table 84 Thailand mutational analysis market, technology, 2021-2033 (USD million)
Table 85 Thailand mutational analysis market, product & service, 2021-2033 (USD million)
Table 86 Thailand mutational analysis market, end use, 2021-2033 (USD million)
Table 87 South Korea mutational analysis market, mutation type, 2021-2033 (USD million)
Table 88 South Korea mutational analysis market, technology, 2021-2033 (USD million)
Table 89 South Korea mutational analysis market, product & service, 2021-2033 (USD million)
Table 90 South Korea mutational analysis market, end use, 2021-2033 (USD million)
Table 91 Latin America mutational analysis market, country, 2021-2033 (USD million)
Table 92 Latin America mutational analysis market, mutation type, 2021-2033 (USD million)
Table 93 Latin America mutational analysis market, technology, 2021-2033 (USD million)
Table 94 Latin America mutational analysis market, product & service, 2021-2033 (USD million)
Table 95 Latin America mutational analysis market, end use, 2021-2033 (USD million)
Table 96 Brazil mutational analysis market, mutation type, 2021-2033 (USD million)
Table 97 Brazil mutational analysis market, technology, 2021-2033 (USD million)
Table 98 Brazil mutational analysis market, product & service, 2021-2033 (USD million)
Table 99 Brazil mutational analysis market, end use, 2021-2033 (USD million)
Table 100 Argentina mutational analysis market, mutation type, 2021-2033 (USD million)
Table 101 Argentina mutational analysis market, technology, 2021-2033 (USD million)
Table 102 Argentina mutational analysis market, product & service, 2021-2033 (USD million)
Table 103 Argentina mutational analysis market, end use, 2021-2033 (USD million)
Table 104 Middle East & Africa mutational analysis market, country, 2021-2033 (USD million)
Table 105 Middle East & Africa mutational analysis market, mutation type, 2021-2033 (USD million)
Table 106 Middle East & Africa mutational analysis market, technology, 2021-2033 (USD million)
Table 107 Middle East & Africa mutational analysis market, product & service, 2021-2033 (USD million)
Table 108 Middle East & Africa mutational analysis market, end use, 2021-2033 (USD million)
Table 109 South Africa mutational analysis market, mutation type, 2021-2033 (USD million)
Table 110 South Africa mutational analysis market, technology, 2021-2033 (USD million)
Table 111 South Africa mutational analysis market, product & service, 2021-2033 (USD million)
Table 112 South Africa mutational analysis market, end use, 2021-2033 (USD million)
Table 113 Saudi Arabia mutational analysis market, mutation type, 2021-2033 (USD million)
Table 114 Saudi Arabia mutational analysis market, technology, 2021-2033 (USD million)
Table 115 Saudi Arabia mutational analysis market, product & service, 2021-2033 (USD million)
Table 116 Saudi Arabia mutational analysis market, end use, 2021-2033 (USD million)
Table 117 UAE mutational analysis market, mutation type, 2021-2033 (USD million)
Table 118 UAE mutational analysis market, technology, 2021-2033 (USD million)
Table 119 UAE mutational analysis market, product & service, 2021-2033 (USD million)
Table 120 UAE mutational analysis market, end use, 2021-2033 (USD million)
Table 121 Kuwait mutational analysis market, mutation type, 2021-2033 (USD million)
Table 122 Kuwait mutational analysis market, technology, 2021-2033 (USD million)
Table 123 Kuwait mutational analysis market, product & service, 2021-2033 (USD million)
Table 124 Kuwait mutational analysis market, end use, 2021-2033 (USD million)
List of Figures
Fig. 1 Mutational analysis market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 Mutational analysis market driver analysis
Figure 12 Mutational analysis market restraint analysis
Figure 13 Mutational analysis market: Porter's five forces analysis
Figure 14 Mutational analysis market: PESTLE analysis
Figure 15 Mutational analysis market: mutation type outlook and key takeaways
Figure 16 Mutational analysis market: mutation type market share analysis
Figure 17 SNVs/point mutations market, 2021-2033 (USD million)
Figure 18 Indels market, 2021-2033 (USD million)
Figure 19 Copy number variants market, 2021-2033 (USD million)
Figure 20 Structural variants market, 2021-2033 (USD million)
Figure 21 Repeat expansions market, 2021-2033 (USD million)
Figure 22 Other mutations market, 2021-2033 (USD million)
Figure 23 Mutational analysis market: technology outlook and key takeaways
Figure 24 Mutational analysis market: technology market share analysis
Figure 25 Sequencing-based market, 2021-2033 (USD million)
Figure 26 PCR-based market, 2021-2033 (USD million)
Figure 27 Microarray-based market, 2021-2033 (USD million)
Figure 28 CRISPR-based market, 2021-2033 (USD million)
Figure 29 Other molecular methods market, 2021-2033 (USD million)
Figure 30 Mutational analysis market: product & service outlook and key takeaways
Figure 31 Mutational analysis market: product & service market share analysis
Figure 32 Instruments & equipment market, 2021-2033 (USD million)
Figure 33 Consumables & reagents market, 2021-2033 (USD million)
Figure 34 Software & bioinformatics market, 2021-2033 (USD million)
Figure 35 Testing & analytical services market, 2021-2033 (USD million)
Figure 36 Mutational analysis market: end use outlook and key takeaways
Figure 37 Mutational analysis market: end use market share analysis
Figure 38 Clinical & diagnostics market, 2021-2033 (USD million)
Figure 39 Precision medicine market, 2021-2033 (USD million)
Figure 40 Research & drug development market, 2021-2033 (USD million)
Figure 41 Academic/CRO research market, 2021-2033 (USD million)
Figure 42 Others market, 2021-2033 (USD million)
Figure 43 Regional marketplace: Key takeaways
Figure 44 North America mutational analysis market, country, 2021-2033 (USD million)
Figure 45 U.S. mutational analysis market, 2021-2033 (USD million)
Figure 46 Canada mutational analysis market, 2021-2033 (USD million)
Figure 47 Mexico mutational analysis market, 2021-2033 (USD million)
Figure 48 Europe mutational analysis market, country, 2021-2033 (USD million)
Figure 49 UK mutational analysis market, 2021-2033 (USD million)
Figure 50 Germany mutational analysis market, 2021-2033 (USD million)
Figure 51 France mutational analysis market, 2021-2033 (USD million)
Figure 52 Italy mutational analysis market, 2021-2033 (USD million)
Figure 53 Spain mutational analysis market, 2021-2033 (USD million)
Figure 54 Denmark mutational analysis market, 2021-2033 (USD million)
Figure 55 Sweden mutational analysis market, 2021-2033 (USD million)
Figure 56 Norway mutational analysis market, 2021-2033 (USD million)
Figure 57 Asia Pacific mutational analysis market, country, 2021-2033 (USD million)
Figure 58 Japan mutational analysis market, 2021-2033 (USD million)
Figure 59 China mutational analysis market, 2021-2033 (USD million)
Figure 60 India mutational analysis market, 2021-2033 (USD million)
Figure 61 Australia mutational analysis market, 2021-2033 (USD million)
Figure 62 Thailand mutational analysis market, 2021-2033 (USD million)
Figure 63 South Korea mutational analysis market, 2021-2033 (USD million)
Figure 64 Latin America mutational analysis market, country, 2021-2033 (USD million)
Figure 65 Brazil mutational analysis market, 2021-2033 (USD million)
Figure 66 Argentina mutational analysis market, 2021-2033 (USD million)
Figure 67 MEA mutational analysis market, country, 2021-2033 (USD million)
Figure 68 South Africa mutational analysis market, 2021-2033 (USD million)
Figure 69 Saudi Arabia mutational analysis market, 2021-2033 (USD million)
Figure 70 UAE mutational analysis market, 2021-2033 (USD million)
Figure 71 Kuwait mutational analysis market, 2021-2033 (USD million)
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 Mutational analysis market driver analysis
Figure 12 Mutational analysis market restraint analysis
Figure 13 Mutational analysis market: Porter's five forces analysis
Figure 14 Mutational analysis market: PESTLE analysis
Figure 15 Mutational analysis market: mutation type outlook and key takeaways
Figure 16 Mutational analysis market: mutation type market share analysis
Figure 17 SNVs/point mutations market, 2021-2033 (USD million)
Figure 18 Indels market, 2021-2033 (USD million)
Figure 19 Copy number variants market, 2021-2033 (USD million)
Figure 20 Structural variants market, 2021-2033 (USD million)
Figure 21 Repeat expansions market, 2021-2033 (USD million)
Figure 22 Other mutations market, 2021-2033 (USD million)
Figure 23 Mutational analysis market: technology outlook and key takeaways
Figure 24 Mutational analysis market: technology market share analysis
Figure 25 Sequencing-based market, 2021-2033 (USD million)
Figure 26 PCR-based market, 2021-2033 (USD million)
Figure 27 Microarray-based market, 2021-2033 (USD million)
Figure 28 CRISPR-based market, 2021-2033 (USD million)
Figure 29 Other molecular methods market, 2021-2033 (USD million)
Figure 30 Mutational analysis market: product & service outlook and key takeaways
Figure 31 Mutational analysis market: product & service market share analysis
Figure 32 Instruments & equipment market, 2021-2033 (USD million)
Figure 33 Consumables & reagents market, 2021-2033 (USD million)
Figure 34 Software & bioinformatics market, 2021-2033 (USD million)
Figure 35 Testing & analytical services market, 2021-2033 (USD million)
Figure 36 Mutational analysis market: end use outlook and key takeaways
Figure 37 Mutational analysis market: end use market share analysis
Figure 38 Clinical & diagnostics market, 2021-2033 (USD million)
Figure 39 Precision medicine market, 2021-2033 (USD million)
Figure 40 Research & drug development market, 2021-2033 (USD million)
Figure 41 Academic/CRO research market, 2021-2033 (USD million)
Figure 42 Others market, 2021-2033 (USD million)
Figure 43 Regional marketplace: Key takeaways
Figure 44 North America mutational analysis market, country, 2021-2033 (USD million)
Figure 45 U.S. mutational analysis market, 2021-2033 (USD million)
Figure 46 Canada mutational analysis market, 2021-2033 (USD million)
Figure 47 Mexico mutational analysis market, 2021-2033 (USD million)
Figure 48 Europe mutational analysis market, country, 2021-2033 (USD million)
Figure 49 UK mutational analysis market, 2021-2033 (USD million)
Figure 50 Germany mutational analysis market, 2021-2033 (USD million)
Figure 51 France mutational analysis market, 2021-2033 (USD million)
Figure 52 Italy mutational analysis market, 2021-2033 (USD million)
Figure 53 Spain mutational analysis market, 2021-2033 (USD million)
Figure 54 Denmark mutational analysis market, 2021-2033 (USD million)
Figure 55 Sweden mutational analysis market, 2021-2033 (USD million)
Figure 56 Norway mutational analysis market, 2021-2033 (USD million)
Figure 57 Asia Pacific mutational analysis market, country, 2021-2033 (USD million)
Figure 58 Japan mutational analysis market, 2021-2033 (USD million)
Figure 59 China mutational analysis market, 2021-2033 (USD million)
Figure 60 India mutational analysis market, 2021-2033 (USD million)
Figure 61 Australia mutational analysis market, 2021-2033 (USD million)
Figure 62 Thailand mutational analysis market, 2021-2033 (USD million)
Figure 63 South Korea mutational analysis market, 2021-2033 (USD million)
Figure 64 Latin America mutational analysis market, country, 2021-2033 (USD million)
Figure 65 Brazil mutational analysis market, 2021-2033 (USD million)
Figure 66 Argentina mutational analysis market, 2021-2033 (USD million)
Figure 67 MEA mutational analysis market, country, 2021-2033 (USD million)
Figure 68 South Africa mutational analysis market, 2021-2033 (USD million)
Figure 69 Saudi Arabia mutational analysis market, 2021-2033 (USD million)
Figure 70 UAE mutational analysis market, 2021-2033 (USD million)
Figure 71 Kuwait mutational analysis market, 2021-2033 (USD million)
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Illumina, Inc
- F. Hoffmann-La Roche Ltd
- QIAGEN
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies plc.
- PacBio
- Takara Bio Inc.
- Revvity
